Details for: FERRIPROX
Company: CHIESI CANADA CORP.
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02436523 | FERRIPROX | DEFERIPRONE | 100 MG / ML | SOLUTION | ORAL |
| 02436531 | FERRIPROX | DEFERIPRONE | 500 MG | TABLET | ORAL |
| 02436558 | FERRIPROX | DEFERIPRONE | 1000 MG | TABLET | ORAL |
Summary Reports
Summary Basis of Decision
Summary Safety Review - Ferriprox (deferiprone) - Assessing the potential risk of brain and nervous system (neurological) disorders in children
Summary Safety Review - Ferriprox (deferiprone) - Assessing the potential risk of brain and nervous system (neurological) disorders in children
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.